Navigation Links
Gene Responsible for Ageing Process Discovered and Calorie Restriction Could Help

In Mahabharat, the famous Indian epic, a prince donates his youth to his father so that he could continue to pursue his passions .

Another kind of help is at hand now. For scientists say they have discovered a gene that plays a central role in the ageing process. And by manipulating that gene perhaps one could live longer, they hope.

The gene appears to be critical in extending the lifespan of animals that are subjected to a calorie-restricted diet -when they are slightly starved of high-calorie food but are given all the other nutrients they need.

It is well established that calorie-restricted diets lead to longer maximum life spans in practically every animal in which they have been studied, although the evidence it not as strong for humans.

"After 72 years of not knowing how calorie restriction works, we finally have genetic evidence to unravel the underlying molecular programme required for increased longevity in response to calorie restriction," said Andrew Dillin, of the Salk Institute in San Diego, California. "It's likely to play a role in the human condition, although we still don't know whether calorie restriction really works in humans. Studies in primates suggest it does."

The latest study focussed on a gene common to nematode worms, mice and humans. When the gene was blocked in the worms, the benefits of a calorie-restricted diet were lost and the worms lived shorter lives. Similarly, when the scientists were able to stimulate the gene they found that they could enhance the longevity of the worms so that their extended life spans came close to matching those worms on a calorie-restricted diet.

Scientists believe that the findings could unlock a genetic treasure-chest of potential pharmacological targets for developing drugs that can extend the human lifespan without having to follow a rigorous and difficult diet.

The first experiments in calorie-restricted diets go back to the
'"/>




Page: 1 2

Related medicine news :

1. PET Scan find the Area of Brain Responsible for Anorexia Nervosa
2. Arsenic May Have Been Responsible For The Madness Of King George III Of England
3. Gene That Might Be Responsible For Aging
4. Enzyme Responsible For Congenital Blindness
5. New Virus Held Responsible For Respiratory Infection In Children
6. Researchers Identify Sipa 1 Gene, Responsible For Cancer Metastasis
7. Nurse Held Responsible For Insulin Overdose
8. Coroner Says Sativex Is Responsible For Death Of Patient
9. Alcohol Is Responsible For 60 Different Diseases
10. Scientists Identify Gene Responsible For Depression
11. Genes That Were Responsible For The Cause Of Blindness Identified
Post Your Comments:
(Date:7/25/2008)... Management to discuss second quarter financial re.../ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) today ...riday, August 8 at 8:30 a.m. (ET) to discuss its s...ll report its second quarter 2008 financial,result...same day., To access the conference call by telep...
(Date:7/25/2008)...f certain cleaning products reduces lung function,... , FRIDAY, July 25 (HealthDay News) -- A clean, ...ealth, depending on what type of cleaning and air ...suggests that exposure to cleaning products or air...c compound (VOC) called 1,4 dicholorobenzene (1,4 ...
(Date:7/25/2008)...ALLAS, July 25 /PRNewswire/ -- BeaconEquity.com an... making news today., Investors can view all of th...//BeaconEquity.com/m , Today,s Trade Alerts inclu...ddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK ), N... ADLR ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abax...
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Beg...all/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI )...unced today that its subsidiary has commenced comm...Capsules USP product in the 40mg,strength from its...tion,with the launch, Watson has 180 days of marke...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2
... has been identified by researchers that help thos...is gene seems to confer a preserving effect upon t...as presented by scientists from the Albert Einstei...sity. December 26, 2006 issue of Neurology publish...
...an holds the hand of a little boy, looking at a ro... area, which was in wreck two years ago, washed aw...m village is exuding life now. Along the innocent-... of Chennai, India, new casurina saplings are knee...
... care is set to boom following expectations of the...ars. // The four per cent increase equates to abou...bated premium of $1,750, will begin in April. The ...include a wide range of medical services including...
...int flavored sweetener, produced naturally by plan...used as an ingredient in chewing gum, toothpaste, ...ist at Agricultural Research Service (ARS) and col...y engineered bacteria, a modified form of Escheric...
Other Medicine News:Health News:You may Live Long and Think Clear With a Variant Gene 2Health News:Tsunami-Hit Coastal Regions Needs More Relief 2Health News:Xylitol To Be Produced By Genetically Engineered E. Coli 2
(Date:7/23/2008)... on IND-Enabling Work with Protein Therapeutics th...ement System, CAMBRIDGE, Mass., July 23 /PRNewswi...t has initiated a corporate growth plan with the,a...utive officer and the,establishment of its headqua...odruff Emlen, M.D., a co-founder of the company wh...
(Date:7/22/2008)...to Discuss Development Plan Completed Successfully... -- Amarin Corporation,plc (NASDAQ: AMRN ) today ...ials at the U.S. Food and Drug Administration (FDA... for the treatment of,hypertriglyceridemia. Follow...o Phase 3 with AMR101 in hypertriglyceridemia., D...
(Date:7/22/2008)...ISCO, Calif., July 22 /- Hyperion,The...ted patient enrollment,in its Phase 1/2 clinical t...nia scavenging effects of HPN-100 (formally called...in patients with urea cycle disorders,(UCD). The c...ourth quarter,of this year., (Logo: http://www.n...
(Date:7/22/2008)... an Individual,s Genetic Risk Based on Clinical Da...Educational Materials, WALTHAM, Mass., July 22 /P... (Amex: ILI ), today announced the launch of an e... for the company,s Heart Health Genetic Test.,The ...nsona(R) Heart Health,Genetic Test by Quixtar/Amwa...
Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3Childrens Hospital of Orange County Chooses RIVA System For Safe and Efficient IV Preparation 11930 1Childrens Hospital of Orange County Chooses RIVA System For Safe and Efficient IV Preparation 11930 2Data from Two Pivotal Trials of AMRIX a New Once Daily Extended Release Muscle Relaxant Presented at the American Academy of Pain Medicine Meeting 3311 1Data from Two Pivotal Trials of AMRIX a New Once Daily Extended Release Muscle Relaxant Presented at the American Academy of Pain Medicine Meeting 3311 2Data from Two Pivotal Trials of AMRIX a New Once Daily Extended Release Muscle Relaxant Presented at the American Academy of Pain Medicine Meeting 3311 3Data from Two Pivotal Trials of AMRIX a New Once Daily Extended Release Muscle Relaxant Presented at the American Academy of Pain Medicine Meeting 3311 4Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 1Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 2Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 3Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 4Technology Transforms Market Research in Pharmaceutical Industry 3309 1Technology Transforms Market Research in Pharmaceutical Industry 3309 2Technology Transforms Market Research in Pharmaceutical Industry 3309 3
...C.--(BUSINESS WIRE)--Jun 12, 2007 - Inspire,Pharma...t,scientists and collaborators related to Inspire ...he European Academy of,Allergology and Clinical Im...eborg, Sweden and at the 30th European Cystic Fibr...16, 2007 in Belek,Turkey., The EAACI Congress inc...
...NDS, Texas--(BUSINESS WIRE)--Jun 11, 2007 - Repros...top-line findings,from its six month study of Proe..., conducted in Europe, enrolled 39,premenopausal w...tudy included three dose levels of Proellex(TM) as...rol was Lucrin(R), a GnRH,agonist also known as Lu...
Other Medicine Technology:Inspire Announces Presentations at Two European Scientific,Conferences 2Inspire Announces Presentations at Two European Scientific,Conferences 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 2Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 4Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 5Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 6
Rotating 360 degrees, 3 mm x 7 mm bite.
Right side cutting.
Backward cutting, 3 mm x 7 mm bite, length of shaft 100 mm, overall length 7 inches.
20 mm. Plastic, methylmethacrylate. Supplied sterile.
Medicine Products: